Maria J. Cruz

Porto, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Prevalence of Regulatory Safety Risk Factors Among Adolescents and Adults With Atopic Dermatitis Receiving Advanced Systemic Therapies: An International Real-World Study.

Prevalence of Regulatory Safety Risk Factors Among Adolescents and Adults With Atopic Dermatitis Receiving Advanced Systemic Therapies: An International Real-World Study.

Journal: International journal of dermatology

Published: July 02, 2026

Generalized Pustular Psoriasis in Portugal: Expert Perspectives on Patient Journey, Diagnosis, Therapeutic Goals, and Healthcare Optimization.

Generalized Pustular Psoriasis in Portugal: Expert Perspectives on Patient Journey, Diagnosis, Therapeutic Goals, and Healthcare Optimization.

Journal: Acta medica portuguesa

Published: January 23, 2026

Hair Improvement in SPINK5-sEDD (Netherton Syndrome) With Dupilumab.

Hair Improvement in SPINK5-sEDD (Netherton Syndrome) With Dupilumab.

Journal: Pediatric dermatology

Published: December 18, 2025

Clinical Trial Eligibility in Atopic Dermatitis: Data from a Large Real-World International Cohort.

Clinical Trial Eligibility in Atopic Dermatitis: Data from a Large Real-World International Cohort.

Journal: Dermatology and therapy

Published: November 14, 2025

Long-Standing Vascular Lesions of the Ear and Periauricular Area: Answer.

Long-Standing Vascular Lesions of the Ear and Periauricular Area: Answer.

Journal: The American Journal of dermatopathology

Published: August 19, 2025

Nongynecologic scar endometriosis with late onset during pregnancy.

Nongynecologic scar endometriosis with late onset during pregnancy.

Journal: Dermatology online journal

Published: July 24, 2025

Long-Standing Vascular Lesions of the Ear and Periauricular Area: Challenge.

Long-Standing Vascular Lesions of the Ear and Periauricular Area: Challenge.

Journal: The American Journal of dermatopathology

Published: June 26, 2025

Real-World Effectiveness, Safety and Drug Survival of Tildrakizumab in Adult Patients With Plaque Psoriasis: A 2-Year Portuguese Multicenter Retrospective Cohort Study.

Real-World Effectiveness, Safety and Drug Survival of Tildrakizumab in Adult Patients With Plaque Psoriasis: A 2-Year Portuguese Multicenter Retrospective Cohort Study.

Journal: International journal of dermatology

Published: June 06, 2025

Real-World Effectiveness and Safety of Dupilumab, Tralokinumab, and Upadacitinib in Patients with Atopic Dermatitis: A 52-Week International, Multicenter Retrospective Cohort Study.

Real-World Effectiveness and Safety of Dupilumab, Tralokinumab, and Upadacitinib in Patients with Atopic Dermatitis: A 52-Week International, Multicenter Retrospective Cohort Study.

Journal: Dermatology and therapy

Published: April 05, 2025

Use of biologics in pediatric-onset hidradenitis suppurativa: a case series.

Use of biologics in pediatric-onset hidradenitis suppurativa: a case series.

Journal: Anais brasileiros de dermatologia

Published: January 24, 2025

Effectiveness and Safety of Adalimumab Biosimilars in Pediatric Psoriasis: A Multi-Center International Experience.

Effectiveness and Safety of Adalimumab Biosimilars in Pediatric Psoriasis: A Multi-Center International Experience.

Journal: Psoriasis (Auckland, N.Z.)

Published: January 12, 2025

Interleukin-4 and Atopic Dermatitis: Why Does it Matter? A Narrative Review.

Interleukin-4 and Atopic Dermatitis: Why Does it Matter? A Narrative Review.

Journal: Dermatology and therapy

Published: December 10, 2024

Showing 1-12 of 39

Last Updated: 09/26/2026